Today, Precision BioLogic unveiled data from a recent study at the 16th International Congress on Antiphospholipid Antibodies (ICAPA 2019) in Manchester, UK.
Heading to Manchester for ICAPA 2019? If so, we'd love to see you. Drop by and visit us at Booth 10. And, be sure to attend our poster presentation, Wednesday, September 18, 12:30–1:30 pm:
Did you know? Each month, the Fritsma Factor features a Quick Question inviting visitors to weigh in on a hemostasis-related topic. At the end of the month, George Fritsma summarizes the results.
Check it out and have your say!
A recording of our May 15 webinar, Update on FVIII Inhibitor Testing and Introduction to the CRYOcheck™ Factor VIII Inhibitor Kit with guest speaker Connie H. Miller, PhD, is now available on Our Webinars page.
Heading to Vancouver for ISLH May 9-11? If so, we’d love to see you. Drop by and visit Precision BioLogic and Affinity Biologicals at booth 503.
Lab Week. In Canada, it's National Medical Laboratory Week. In the U.S., it's Medical Laboratory Professionals Week. No matter what you call it, it's a time to recognize clinical laboratory professionals and all that they bring to their vital role in health care.
Lab Week runs April 21–27 this year. In support, we're hosting a FREE WEBINAR next month:
April 17 is World Hemophilia Day and Precision BioLogic is proud to support this important World Federation of Hemophilia initiative. This year, the focus is on outreach and identification as the “first step to care." Visit worldhemophiliaday.org to share your stories of diagnosis along with efforts to increase outreach and identification.
Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce FDA 510(k) clearance and the launch of its CRYOcheck™ Factor VIII Inhibitor Kit in the U.S. This clearance follows approvals received from regulatory authorities in Canada, the European Union, Australia, and New Zealand, where the kit launched in February of this year.
Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the availability of its new CRYOcheck™ Factor VIII Inhibitor Kit in Canada, the European Union, Australia, and New Zealand following market authorization by Health Canada and respective in-country regulatory authorities last month.
2019 is upon us and we're gearing up for an eventful year. Check out our updated list of conferences. We hope to see you there!
On December 1, Precision BioLogic unveiled data from a study using a new kit for a Modified Nijmegen-Bethesda Assay (MNBA) at the 60th ASH Annual Meeting in San Diego, CA.
HALIFAX, November 1, 2018—Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the completed acquisition of Affinity Biologicals Inc., a primary manufacturer of reagents and kits used in hemostasis and thrombosis research and diagnostics.
Members of the Precision BioLogic team will be at the following events:
Clinical and Laboratory Update in Thrombosis and Anticoagulation
Oct 31–Nov 2 in Scottsdale, AZ
Nov 1–3 in Halifax, NS
We'd love to see you. If you are attending either of these events, please be sure to drop by our booth and say hello.